Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The US market for ambulatory ECG monitoring devices will experience high growth through 2027 as providers move to outsourcing and increasingly use longer-term monitoring devices, such as ICMs and telemetry.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ambulatory ECG monitoring devices in the US across a 10-year period.
What are some of the fastest growing indications for ambulatory ECG monitoring?
How does the growth of key patient populations, like AF and stroke, differ over the forecast period?
How have changes in clinical guidelines changed physician behaviour when prescribing these devices?
How is the mix of ambulatory ECG monitoring devices changing over time?
Which monitoring device segments will experience the fastest growth? What device segments will be cannibalized by the adoption of newer types of longer term monitoring?
What barriers, such as restrictive reimbursement policy, hinder the adoption of newer types of monitoring?
Which companies have a large share in this market and how will this change over time?
How will the adoption of newer devices, like telemetry and patch based devices, change market shares?
How do competitors differentiate their products and services? What do providers value in ambulatory ECG monitoring devices and services?
Already a Client? Log in to access this report.
Erik J. Bracciodieta is a senior analyst within the Cardiovascular Medtech Insights team, specializing in cardiac rhythm management and structural heart closure device markets, as well as medical device pricing and regulations in Japan. Erik holds a Master's degree in Biotechnology from the University of Toronto. Follow Erik on Twitter: @ErikB_DRG.